Navigating the Complexities of Pain Management Drug Development

 Dr. Stephen Waxman is a professor of neurology, neuroscience and pharmacology at Yale. His research on pain helped pave the way for a newly approved, non-addictive pain drug called suzetrigine.

On today’s show, he explains why he thinks suzetrigine is a promising step, but why much more work is needed to develop better pain drugs. He also gets into his work on ion channels—critical to unlocking the pain puzzle— and a rare condition known as Man on Fire syndrome.

See omnystudio.com/listener for privacy information.